Moderna has announced an agreement with Blackstone Life Sciences, receiving a $750 million investment to develop its mRNA flu vaccines. This collaboration aims to bolster Moderna's efforts in advancing multiple vaccines, particularly in response to a post-COVID slump in sales. Blackstone's investment represents 7% of the total investment in mRNA technology at Moderna, compared to the US government's $10 billion contribution. Additionally, Blackstone will receive commercial milestone payments and royalties from Moderna. This strategic move by Blackstone underscores its commitment to supporting innovative mRNA technology.
Blackstone Life Sciences is making a $750 million bet on Moderna’s influenza vaccine program as part of the investment platform’s push to “support innovative mRNA technology.” https://t.co/AY3nCPIXTd
Moderna said on Wednesday Blackstone's life sciences arm would offer $750 million in funding towards its flu vaccines, bolstering its efforts to advance multiple vaccines to stem a post-COVID slump in sales. https://t.co/t6sTzmlw8H https://t.co/t6sTzmlw8H
$750 Ms - I Fink that Blackstone moves in size….🤑 Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program https://t.co/MimQWOPk8X
Moderna secures $750 mln from Blackstone Life Sciences to develop flu shots https://t.co/qJYzXH8hdo https://t.co/aJioaMoKde
For those keeping track, Blackstone has invested 7% ($750mn) of what the US government has invested ($10bn) in mRNA technology at Moderna alone. Blackstone gets 'commercial milestone payments' and royalties. In contrast, NIH had to threaten legal action. https://t.co/SjuHBqzmAa https://t.co/fLWuS8cHXS
Moderna said on Wednesday it has entered into an agreement with private equity firm Blackstone's life science investment platform for a funding of $750 million to develop its mRNA flu vaccines. https://t.co/37dV03H4FH https://t.co/37dV03H4FH
⚠️ MODERNA GETS $750 MILLION FUNDING FROM BLACKSTONE LIFE SCIENCES TO DEVELOP FLU SHOTS Full Story → https://t.co/ITSDNAsCAL https://t.co/1ZEteiKY8b